The Automatic Insulin Delivery Systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms).
Asia-Pacific region is the largest and fastest-growing market during the forecast period.

The global Automatic Insulin Delivery Systems market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Automatic Insulin Delivery Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Automatic Insulin Delivery Systems market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Eli Lily
Tandem
Insulet
Big Foot Biomedical
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Type I Diabetes
Type II Diabetes

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics